Table 6. Cited and citing references of Cluster #0 neonatal seizures.
| Cluster #0 neonatal seizures | |||
|---|---|---|---|
| Cited references | Citing articles | ||
| Cites | Author (year) journal, volume, page | Coverage (%) | Author (year) title |
| 134 | Tomson T (2011) Lancet Neurol, V10, P609 | 18 | Eadie, MJ (2014) Treating epilepsy in pregnant women |
| 97 | Meador KJ (2009) New Engl J Med, V360, P1597 | 15 | Tomson, T (2012) Teratogenic effects of antiepileptic drugs |
| 83 | Hernandez-diaz S (2012) Neurology, V78, P1692 | 10 | Borthen, I (2012) Pregnancy complications in patients with epilepsy |
| 78 | Meador KJ (2013) Lancet Neurol, V12, P244 | 9 | Hill, DS (2010) Teratogenic effects of antiepileptic drugs |
| 62 | Christensen J (2013) Jama-J AM Med Assoc, V309, P1696 | 9 | Holmes, LB (2012) Newer anticonvulsants: lamotrigine, topiramate and gabapentin |
| 60 | Meador K (2008) Epilepsy Res, V81, P1 | 7 | Bobo, WV (2015) Trends in the use of antiepileptic drugs among pregnant women in the us, 2001-2007: a medication exposure in pregnancy risk evaluation program study |
| 52 | Molgaard-nielsen D (2011) Jama-J AM Med Assoc, V305, P1996 | 7 | Vajda, FJE (2014) The efficacy of the newer antiepileptic drugs in controlling seizures in pregnancy |
| 51 | Jentink J (2010) New Engl J Med, V362, P2158 | 7 | Voinescu, PE (2017) Delivery of a personalized treatment approach to women with epilepsy |
Note:
Cluster label terms are bold.